1. Home
  2. CRIS vs FRSX Comparison

CRIS vs FRSX Comparison

Compare CRIS & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • FRSX
  • Stock Information
  • Founded
  • CRIS 2000
  • FRSX N/A
  • Country
  • CRIS United States
  • FRSX Israel
  • Employees
  • CRIS N/A
  • FRSX N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • CRIS Health Care
  • FRSX Technology
  • Exchange
  • CRIS Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • CRIS 22.9M
  • FRSX 8.2M
  • IPO Year
  • CRIS 2000
  • FRSX 2017
  • Fundamental
  • Price
  • CRIS $1.71
  • FRSX $2.09
  • Analyst Decision
  • CRIS Strong Buy
  • FRSX
  • Analyst Count
  • CRIS 2
  • FRSX 0
  • Target Price
  • CRIS $16.50
  • FRSX N/A
  • AVG Volume (30 Days)
  • CRIS 74.8K
  • FRSX 73.7K
  • Earning Date
  • CRIS 11-13-2025
  • FRSX 09-21-2025
  • Dividend Yield
  • CRIS N/A
  • FRSX N/A
  • EPS Growth
  • CRIS N/A
  • FRSX N/A
  • EPS
  • CRIS N/A
  • FRSX N/A
  • Revenue
  • CRIS $11,405,000.00
  • FRSX $452,000.00
  • Revenue This Year
  • CRIS $1.41
  • FRSX N/A
  • Revenue Next Year
  • CRIS $7.46
  • FRSX N/A
  • P/E Ratio
  • CRIS N/A
  • FRSX N/A
  • Revenue Growth
  • CRIS 12.24
  • FRSX N/A
  • 52 Week Low
  • CRIS $1.02
  • FRSX $1.98
  • 52 Week High
  • CRIS $6.44
  • FRSX $18.41
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 48.53
  • FRSX 47.59
  • Support Level
  • CRIS $1.63
  • FRSX N/A
  • Resistance Level
  • CRIS $1.95
  • FRSX $2.63
  • Average True Range (ATR)
  • CRIS 0.15
  • FRSX 0.15
  • MACD
  • CRIS 0.01
  • FRSX -0.08
  • Stochastic Oscillator
  • CRIS 29.41
  • FRSX 79.47

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: